Femasys Inc
Ownership
Ownership Structure
Who owns Femasys Inc (FEMY)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.7% of the shares are freely tradable; institutional investors hold 10.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Dauntless Investment Group, LLC | 3.60 | 6,033,030 | +1.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 0.74 | 1,236,673 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 0.37 | 621,366 | +59.6 | 03/31/2026 |
| Citadel Advisors Llc | 0.20 | 16,921 | +0.0 | 06/30/2026 |
| Vanguard Fiduciary Trust Co | 0.15 | 249,876 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.11 | 178,501 | +31.8 | 03/31/2026 |
| Northern Trust Corp | 0.07 | 118,411 | +57.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 0.41 | 34,296 | +0.0 | 07/31/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.33 | 27,936 | +0.0 | 07/31/2026 |
| Fidelity Extended Market Index | 0.18 | 15,065 | -0.2 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Elefant Dov | Chief Financial Officer | 15,625 | 40,625 $ | Aug 7, 2026 | direct |
| Lee-Sepsick Kathy | Chief Executive Officer | 15,625 | 40,625 $ | Aug 7, 2026 | direct |
| Canning John Charles | Chief Operating Officer | 4,375 | 11,375 $ | Aug 7, 2026 | direct |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 3,125 | 8,125 $ | Aug 7, 2026 | direct |
| Sipos Jeremy Alexander | Chief Technology Officer | 3,125 | 8,125 $ | Aug 7, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | Buy | 3,125 | 3.20 | 10,000 |
| Aug 7, 2026 | Sipos Jeremy Alexander | Chief Technology Officer | Buy | 3,125 | 3.20 | 10,000 |
| Aug 7, 2026 | Canning John Charles | Chief Operating Officer | Buy | 4,375 | 3.20 | 14,000 |
| Aug 7, 2026 | Elefant Dov | Chief Financial Officer | Buy | 15,625 | 3.20 | 50,000 |
| Aug 7, 2026 | Lee-Sepsick Kathy | Chief Executive Officer | Buy | 15,625 | 3.20 | 50,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.